KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $59,000 | -68.6% | 13,137 | -27.9% | 0.01% | -72.2% |
Q2 2021 | $188,000 | -62.0% | 18,229 | -61.3% | 0.02% | -48.6% |
Q1 2021 | $495,000 | -36.1% | 47,054 | -6.1% | 0.04% | -58.3% |
Q4 2020 | $775,000 | +682.8% | 50,086 | +387.8% | 0.08% | +950.0% |
Q3 2019 | $99,000 | -49.2% | 10,267 | -10.5% | 0.01% | -33.3% |
Q3 2018 | $195,000 | -41.3% | 11,466 | -53.6% | 0.01% | -33.3% |
Q1 2018 | $332,000 | +65.2% | 24,710 | +35.1% | 0.02% | +80.0% |
Q3 2017 | $201,000 | – | 18,293 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |